Wendell Wierenga

Wendell Wierenga

Fortune : 7 M $ au 31/05/2026

78 ans
Health Technology
Consumer Services
Commercial Services

Profil

Wendell D.
Wierenga
is Chairman at Crinetics Pharmaceuticals, Inc. since 2015.
Dr. Wierenga is Independent Director at Cytokinetics, Inc. since 2011.
Dr. Wierenga is Independent Director at Dermata Therapeutics, Inc. since 2016.
Former roles include Chief Executive Officer at Syrrx, Inc. from 1999 to 2004.
Executive Director-Discovery Research at Pharmacia & Upjohn, Inc. Executive Director-Discovery Research at The Upjohn Co. from 1974 to 1990.
Independent Director at Onyx Pharmaceuticals, Inc. from 2011 to 2013.
Independent Director at Apricus Biosciences, Inc. from 2014 to 2019.
Director at Aspira Women's Health, Inc. from 2003 to 2006.
Director at Patara Pharma LLC.
Director at SRI International.
Independent Director at XenoPort, Inc. from 2011 to 2016.
Independent Director at OCERA Therapeutics LLC from 2013 to 2017.
Independent Director at Anacor Pharmaceuticals LLC from 2015 to 2016.
Independent Director at Concert Pharmaceuticals, Inc. from 2014 to 2019.
Vice President-Medtech Ventures at Warner-Lambert Co. from 1992 to 2000.
Executive Vice President-Research & Development at Santarus, Inc. from 2011 to 2014.
Senior Vice President-Research at Parke-Davis Pharmaceutical Research, Inc. from 1990 to 2000.
Executive Vice President-Research & Development at Neurocrine Biosciences, Inc. from 2004 to 2006.
Senior VP-Worldwide Pharmaceutical Sciences at Pfizer Inc. from 1990 to 2000.
Executive Vice President-Research & Development at Ambit Biosciences Corp.
from 2007 to 2011.
Education includes a doctorate from Stanford University and undergraduate degree from Hope College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/04/2026 109 246 ( 0,12 % ) 4 M $ 31/05/2026
27/05/2026 35 488 ( 0,03 % ) 3 M $ 31/05/2026
30/03/2026 25 ( 0 % ) 33 $ 31/05/2026

Postes actifs de Wendell Wierenga

SociétésPosteDébut
CYTOKINETICS, INCORPORATED Directeur/Membre du Conseil 09/02/2011
CRINETICS PHARMACEUTICALS, INC. Président 01/10/2015
DERMATA THERAPEUTICS, INC. Directeur/Membre du Conseil 20/09/2016

Anciens postes connus de Wendell Wierenga

SociétésPosteFin
Directeur/Membre du Conseil 24/01/2019
CONCERT PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/01/2019
Directeur/Membre du Conseil 01/11/2018
OCERA THERAPEUTICS INC Directeur/Membre du Conseil 11/12/2017
XENOPORT, INC. Directeur/Membre du Conseil 01/08/2016
Voir l'expérience en détail de Wendell Wierenga

Formation de Wendell Wierenga

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

72

Relations au 1er degré

23

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées23

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Parke-Davis Pharmaceutical Research, Inc.

Health Technology

  1. Bourse
  2. Insiders
  3. Wendell Wierenga
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇